Integra Lifesciences Holdings Corp

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC IART

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

196,187

Value ($000)

2,437

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,437	0.0%	196,187	12/31/2025
2025 Q3	11/14/2025	2,908	0.0%	202,956	9/30/2025
2025 Q2	8/14/2025	3,781	0.0%	308,139	6/30/2025
2025 Q1	5/19/2025	5,373	0.0%	244,335	3/31/2025
2024 Q4	2/14/2025	4,505	0.0%	198,642	12/31/2024
2024 Q3	11/14/2024	3,092	0.0%	170,185	9/30/2024
2024 Q2	8/14/2024	4,973	0.0%	170,651	6/30/2024
2024 Q1	5/15/2024	4,156	0.0%	117,239	3/31/2024
2023 Q4	2/14/2024	5,117	0.0%	117,496	12/31/2023
2023 Q3	11/13/2023	4,487	0.0%	117,496	9/30/2023
2023 Q2	8/11/2023	6,669	0.0%	116,162	6/30/2023
2023 Q1	5/15/2023	6,669	0.0%	116,162	3/31/2023
2022 Q4	2/14/2023	5,643	0.0%	100,650	12/31/2022
2022 Q3	11/14/2022	3,893	0.0%	91,909	9/30/2022
2022 Q2	8/12/2022	6,174	0.0%	114,269	6/30/2022
2022 Q1	5/16/2022	7,219	0.0%	112,333	3/31/2022
2021 Q4	2/14/2022	7,057	0.0%	105,338	12/31/2021
2021 Q3	11/15/2021	7,417	0.0%	108,305	9/30/2021
2021 Q2	8/16/2021	7,356	0.0%	107,795	6/30/2021
2021 Q1	5/14/2021	7,321	0.0%	105,959	3/31/2021
2020 Q4	3/1/2021	7,595	0.0%	116,993	12/31/2020
2020 Q3	11/13/2020	4,774	0.0%	101,097	9/30/2020
2020 Q2	8/14/2020	4,492	0.0%	95,588	6/30/2020
2020 Q1	5/15/2020	4,385	0.0%	98,161	3/31/2020
2019 Q4	2/14/2020	5,168	0.0%	88,675	12/31/2019
2014 Q1	5/23/2014	354	0.0%	7,700	3/31/2014
2013 Q4	1/31/2014	339	0.0%	7,100	12/31/2013